Cargando…
Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19
Coronavirus disease 2019 (COVID-19) is a highly infectious epidemic disease that has seriously affected human health worldwide. To date, however, there is still no definitive drug for the treatment of COVID-19. Cell-based therapies could represent a new breakthrough. Over the past several decades, m...
Autores principales: | Lu, Kun, Geng, Shi-tao, Tang, Shikai, Yang, Hua, Xiong, Wei, Xu, Fang, Yuan, Qijun, Xiao, Xian, Huang, Renqiang, Liang, Haihui, Chen, Zhipeng, Qian, Chuanyun, Li, Yang, Wang, Songqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822653/ https://www.ncbi.nlm.nih.gov/pubmed/35130977 http://dx.doi.org/10.1186/s13287-022-02743-0 |
Ejemplares similares
-
Metformin induces apoptosis in mesenchymal stromal cells and dampens their therapeutic efficacy in infarcted myocardium
por: He, Xiao, et al.
Publicado: (2018) -
Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic Cardiomyopathy
por: Tang, Xian-Liang, et al.
Publicado: (2023) -
The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy
por: Weiss, Daniel J., et al.
Publicado: (2019) -
Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: A systematic review and meta-analysis
por: Yang, Cong-wen, et al.
Publicado: (2022) -
Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity
por: Liang, Shu-Man, et al.
Publicado: (2017)